<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01663675</url>
  </required_header>
  <id_info>
    <org_study_id>5249</org_study_id>
    <nct_id>NCT01663675</nct_id>
  </id_info>
  <brief_title>Trisomy 21 in Adulthood</brief_title>
  <official_title>Trisomy 21 in Adulthood. Evaluation of Health and Social State in Alsace (North-eastern France)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trisomy 21 or Down syndrome, is the most common genetic cause of cognitive disability.
      Currently, in Alsace, the birth prevalence is about 1 in 1600 live births, which means 10
      liveborns with Down syndrome each year.If screening and prenatal diagnosis of children with
      trisomy 21, as well as medical care, social and educational integration in childhood was the
      subject of much research and has led to remarkable progress in terms of health and medical
      care, it is not the same for the knowledge about adolescents and adults.Despite a more and
      more higher life expectancy, the evolution of trisomy 21 in adulthood is often marked by a
      deterioration in health status, with a regression of acquired psychomotor skills, often
      attributed only to the precocious occurrence of Alzheimer's dementia. Nevertheless, it seems
      that the diagnosis of Alzheimer's dementia is often overdiagnosed, and it is well established
      that only a fraction of Down syndrome patients will develop this type of dementia. Too often
      a decline in general health, behavioral changes and decreased cognitive abilities are only
      attributed to the Down syndrome with an early dementia without looking for an underlying,
      potentially curable, disease.This study aims to better evaluate the health and social status
      of 100 adults with trisomy 21 in Alsace. The medical evaluation will include a comprehensive
      assessment of health status and quality of life conducted by the geneticist, a cardiac,
      sensory, hormonal, biological and radiological evaluation. A speech-language and psychomotor
      evaluation will also be conducted. A psychiatric consultation and a psychometric assessment
      will aim to assess cognitive function and to search for associated mood disorders.The
      expected results are to better know the natural history of trisomy 21 in adulthood, with the
      determination of the frequency of morbid events specific to adulthood, and also to improve
      the medical and paramedical care with the establishment of a monitoring program to prevent
      the occurrence of these morbid events.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Down Syndrome</condition>
  <arm_group>
    <arm_group_label>Trisomy 21 (Down syndrome)</arm_group_label>
    <description>Trisomy 21 (Down syndrome)</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>karyotype</intervention_name>
    <arm_group_label>Trisomy 21 (Down syndrome)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cases with trisomy 21 older than 18 years living in Alsace Region (North-eastern France)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman older than 18 years

          -  Down syndrome (clinical diagnosis, eventually confirmed by blood karyotype)

        Exclusion Criteria:

          -  children

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ALEMBIK Yves, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ALEMBIK Yves, MD</last_name>
    <phone>33.3.88.12.50.89</phone>
    <email>yves.alembik@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ALEMBIK Yves, MD</last_name>
      <phone>33.3.88.12.50.89</phone>
      <email>yves.alembik@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>ALEMBIK Yves, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>SCHAEFER Elise, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>EL CHEHADEH Salima, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>DOLLFUS Hélène, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>TIMBOLSCHI Dana Luiza, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>CHRISTMANN Dominique, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>MANIERE Marie-Cécile, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>DAVIDEAU Jean-Luc, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>KOENIG Anne, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>ROUL Gérard José, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>PETIT-EISENMANN Hélène, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>BLOCH-ZUPAN Agnès, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>BERNA Fabrice, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>PRADIGNAC Alain, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>GUFFROY Aurélien, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>KREMER Stéphane, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>PERDOMO-TRUJILLO Yaumara, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>KORGANOW Anne-Sophie, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>BLANC Frédéric, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>GAZZANO Elise, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>BRUN Isabelle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>HIEBEL Jean-Michel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2012</study_first_submitted>
  <study_first_submitted_qc>August 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2012</study_first_posted>
  <last_update_submitted>November 22, 2016</last_update_submitted>
  <last_update_submitted_qc>November 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Down syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Down Syndrome</mesh_term>
    <mesh_term>Trisomy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

